Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Operating Leases (2019 - 2026)

Rockwell Medical filings provide 7 years of Operating Leases readings, the most recent being $1.5 million for Q4 2025.

  • On a quarterly basis, Operating Leases fell 14.42% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 14.42% decrease, with the full-year FY2025 number at $1.5 million, down 14.42% from a year prior.
  • Operating Leases hit $1.5 million in Q4 2025 for Rockwell Medical, down from $3.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $5.9 million in Q4 2021 to a low of $1.4 million in Q1 2025.
  • Median Operating Leases over the past 5 years was $2.8 million (2022), compared with a mean of $3.3 million.
  • Biggest five-year swings in Operating Leases: surged 274.19% in 2021 and later plummeted 67.59% in 2023.
  • Rockwell Medical's Operating Leases stood at $5.9 million in 2021, then tumbled by 56.16% to $2.6 million in 2022, then crashed by 44.48% to $1.4 million in 2023, then grew by 18.56% to $1.7 million in 2024, then decreased by 14.42% to $1.5 million in 2025.
  • The last three reported values for Operating Leases were $1.5 million (Q4 2025), $3.0 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.